Medpace Holdings (MEDP) Operating Margin (2015 - 2026)

Medpace Holdings has reported Operating Margin for 12 years, with the latest figure at 20.03% in Q1 2026.

• For the quarter ending Q1 2026, Operating Margin fell 30.0% year-over-year to 20.03%; the trailing twelve-month figure through Mar 2026 stood at 21.02% (down 14.0% YoY), and the FY2025 full-year result was 21.14%, down 5.0% from the prior year.
• Operating Margin for Q1 2026 stood at 20.03%, down from 21.63% in the prior quarter.
• The five-year high for Operating Margin was 23.37% in Q4 2024, with the low at 17.01% in Q2 2023.
• Historically, Operating Margin has averaged 19.82% across 5 years, with a median of 20.03% in 2026.
• Annual changes were most pronounced in 2023 — Operating Margin sank 304 bps — and 2024, when it soared 585 bps.
• Medpace Holdings' Operating Margin stood at 19.39% in 2022, then decreased by 10 bps to 17.52% in 2023, then jumped by 33 bps to 23.37% in 2024, then declined by 7 bps to 21.63% in 2025, then retreated by 7 bps to 20.03% in 2026.
• The last three Operating Margin figures came in at 20.03% (Q1 2026), 21.63% (Q4 2025), and 21.49% (Q3 2025), per Business Quant data.